Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
William Blair Maintains Outperform on Dianthus Therapeutics (DNTH) March 2026
William Blair has reiterated its Outperform rating on Dianthus Therapeutics (DNTH) as of March 16, 2026, signaling continued confidence in the company’s development pipeline and commercial prospects without issuing a new price target. This recommitment comes after Dianthus priced an upsized offering, raising approximately $625 million. Meyka AI rates DNTH with a B+ grade, highlighting important catalysts like planned clinical readouts and regulatory interactions.